Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex maintenance in neuropathic pain
NCT00713817Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Mar 2007
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in neuropathic pain, sponsored by Jazz Pharmaceuticals plc. Started Mar 2007; status: completed.
02
Drugs
cannabidiol
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00713817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713817.